Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,113

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: NJ ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 15, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall United States Terminated Historical recordClass III

Corim International Coffee Inc.

Product: Jersey Charm, 24 ct single serve coffee pods (12.7 oz. carto…
Reason: Corim Industries, 1112 Industrial Parkway, Brick, NJ 08724 is initiating a recall of Agglomerated Peanut Butter Hot Chocolate, Peanut Butter Cappuccino, 500lb sacks; single serve cups (15g), single serve packets (28g) because of undeclared peanut allergen.
Published: March 8, 2023
Distribution: The product was distributed to the follo…

View recall →

FDA Recall United States Terminated Historical recordClass III

Corim International Coffee Inc.

Product: Smart Sips, 24 ct single serve coffee pods (12.7 oz carton)
Reason: Corim Industries, 1112 Industrial Parkway, Brick, NJ 08724 is initiating a recall of Agglomerated Peanut Butter Hot Chocolate, Peanut Butter Cappuccino, 500lb sacks; single serve cups (15g), single serve packets (28g) because of undeclared peanut allergen.
Published: March 8, 2023
Distribution: The product was distributed to the follo…

View recall →

FDA Recall United States Terminated Historical recordClass III

Corim International Coffee Inc.

Product: Cocoa de Aroma, 24 ct single serve coffee pods assorted (12.…
Reason: Corim Industries, 1112 Industrial Parkway, Brick, NJ 08724 is initiating a recall of Agglomerated Peanut Butter Hot Chocolate, Peanut Butter Cappuccino, 500lb sacks; single serve cups (15g), single serve packets (28g) because of undeclared peanut allergen.
Published: March 8, 2023
Distribution: The product was distributed to the follo…

View recall →

FDA Recall United States Terminated Historical recordClass I

DAISO CALIFORNIA WAREHOUSE

Product: Matsunaga Mini Shiruko Sand Biscuits 100 g packages, contain…
Reason: Product was found to contain the allergen of soy that was not listed on the ingredient label.
Published: March 8, 2023
Distribution: Product was distributed to customer loca…

View recall →

FDA Recall United States Terminated Historical recordClass II

Alpenland International, Inc.

Product: HEILEMANN CONFISERIE WEHNACHTSFIGUREN AUS EDELVOLLMILCH-SCHO…
Reason: The manufacturer informed the firm that they received a complaint of plastic in the product.
Published: March 8, 2023
Distribution: Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass II

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

by RISING PHARMACEUTICALS

Reason: Failed Impurities/Degradation Specifications
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass II

0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-10

by B. Braun Medical Inc.

Reason: Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass II

0.9% Sodium Chloride Injection, USP, 1000 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00

by B. Braun Medical Inc.

Reason: Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0160-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0150-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0145-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0135-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0125-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0120-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0117-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0115-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0113-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0112-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0110-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0155-5

by IBSA PHARMA INC

Reason: Subpotent Drug
Published: March 1, 2023
Distribution: Nationwide

View recall →

Data last updated: September 15, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.